Stereoselective synthesis of novel C-3 functionalized 3-sulfonyl-β-lactams: Promising biologically active heterocyclic scaffolds
-
Add time:09/26/2019 Source:sciencedirect.com
An efficient and operationally simple strategy for the stereoselective synthesis of novel C-3 functionalized 3-sulfonyl-β-lactam heterocycles is described. The C-3 functionalized 3-phenyl/benzylsulfonyl-β-lactams 3/3′, 5/5′ has been synthesized via Michael addition using different Michael acceptors on trans-3-phenyl/benzylsulfonyl-β-lactams 2(a–f) using K2CO3 as a base and acetonitrile/DMF as solvents. The reaction furnished exclusively cis-β-lactam adducts 3(a–r) using sterically less hindered Michael acceptors. Further, the effect of steric bulk and chiralilty of Michael acceptors was explored to achieve target C-3 functionalized β-lactams 3(s-u)/3′(s-u) and 5(a–c)/5′(a–c). The structural and stereochemical analysis of novel β-lactams were carried out using FT-IR, NMR (1H, 13C, 1H-1H COSY, 1H-13C COSY and 13C DEPT-135), elemental analysis (CHNS), mass spectrometry (EIMS and LCMS) in representative cases and single crystal X-ray crystallographic studies (3e). The cis or trans configuration of the Michael acceptor (E) at C-3 was assigned with respect to C4-H.
We also recommend Trading Suppliers and Manufacturers of 3-(PHENYLSULFONYL)ACRYLONITRILE (cas 1424-51-7). Pls Click Website Link as below: cas 1424-51-7 suppliers
Prev:Original article2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: New series of highly potent and specific serotonin 5-HT6 receptor antagonists
Next:Approximate rate constants for intermolecular additions of alkyl radicals to phenylsulfonyl oxime ethers) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Methyl 3-phenylsulfonyl orthopropionate: A new reagent for cyclopentannulation10/01/2019
- Approximate rate constants for intermolecular additions of alkyl radicals to phenylsulfonyl oxime ethers09/27/2019
- Original article2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: New series of highly potent and specific serotonin 5-HT6 receptor antagonists09/25/2019


